Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.53 - $0.84 $1,867 - $2,959
3,523 Added 6.65%
56,519 $33,000
Q3 2023

Nov 13, 2023

BUY
$0.71 - $1.36 $22,259 - $42,638
31,352 Added 144.85%
52,996 $38,000
Q2 2023

Aug 11, 2023

SELL
$0.85 - $1.44 $497 - $842
-585 Reduced 2.63%
21,644 $28,000
Q2 2022

Aug 12, 2022

BUY
$2.16 - $6.36 $48,014 - $141,376
22,229 New
22,229 $48,000

Others Institutions Holding XCUR

About EXICURE, INC.


  • Ticker XCUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,962,580
  • Market Cap $55.5M
  • Description
  • Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...
More about XCUR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.